BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7007326)

  • 1. Biological consequences of infection of Escherichia coli B by alkylated T7 bacteriophage.
    Karska-Wysocki B; Mamet-Bratley MD
    J Bacteriol; 1981 Jan; 145(1):573-82. PubMed ID: 7007326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inhibition of bacteriophage T7 DNA synthesis in Escherichia coli B cells infected by alkylated bacteriophage T7.
    Czaika G; Mamet-Bratley MD; Karska-Wysocki B
    Mutat Res; 1986 Jul; 166(1):1-8. PubMed ID: 3523227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-cell reactivation of alkylated T7 bacteriophage.
    Lane D; Mamet-Bratley MD; Karska-Wysocki B
    Biochim Biophys Acta; 1979 Oct; 564(3):495-506. PubMed ID: 387086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of morphogenetic intermediates and progeny of normal and alkylated bacteriophage T7.
    Karska-Wysocki B; Zollinger M; Mamet-Bratley MD
    Virology; 1987 Apr; 157(2):285-97. PubMed ID: 3548034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective DNA injection by alkylated and nonalkylated bacteriophage T7.
    Czaika G; Mamet-Bratley MD
    Biochim Biophys Acta; 1992 Feb; 1130(1):52-62. PubMed ID: 1543749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [protein synthesis in alkylated bacteriophage T7].
    Racine JF; Karska-Wysocki B; Mamet-Bratley MD
    Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):885-93. PubMed ID: 1477605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible reactivation of bacteriophage T7 damaged by methyl methanesulfonate or UV light.
    Dodson LA; Masker WE
    J Bacteriol; 1983 Oct; 156(1):13-8. PubMed ID: 6352671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicity reactivation of bacteriophage T7 inactivated by methyl methanesulfonate.
    Karska-Wysocki B; Mamet-Bratley MD
    J Virol; 1984 Dec; 52(3):1009-10. PubMed ID: 6387176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of T7 development at high concentrations of the phage.
    Haarr L; Jensen HB; Helland DE
    J Gen Virol; 1981 Mar; 53(Pt 1):115-23. PubMed ID: 7024471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of toxicity of 3-methyladenine for bacteriophage T7.
    Racine JF; Zhu Y; Mamet-Bratley MD
    Mutat Res; 1993 Oct; 294(3):285-98. PubMed ID: 7692268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkylation of T7 bacteriophage blocks superinfection exclusion.
    Karska-Wysocki B; Racine JF; Mamet-Bratley MD
    J Virol; 1982 Nov; 44(2):708-10. PubMed ID: 6754970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection defect in alkylated and depurinated T7 bacteriophage: analysis by DNA ejection.
    Mamet-Bratley MD; Zollinger M; Karska-Wysocki B
    Can J Biochem; 1982 Mar; 60(3):232-42. PubMed ID: 7044500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro host cell reactivation of alkylated bacteriophage T7 deoxyribonucleic acid by repair-deficient strains of Escherichia coli.
    Dodson LA; Masker WE
    J Bacteriol; 1981 Sep; 147(3):720-7. PubMed ID: 7024247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of bacteriophage T7 head-related particles in an Escherichia coli mutant.
    Yamada Y; Silnutzer J; Nakada D
    J Virol; 1979 Jul; 31(1):209-19. PubMed ID: 387976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the T7 coliphage by monofunctional alkylating agents. Action of phage adsorption and injection of its DNA.
    Karska-Wysocki B; Thibodeau L; Verly WG
    Biochim Biophys Acta; 1976 Jun; 435(2):184-91. PubMed ID: 181068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of Escherichia coli CRISPR-Cas system on lytic bacteriophages with different lifestyles and development strategies.
    Strotskaya A; Savitskaya E; Metlitskaya A; Morozova N; Datsenko KA; Semenova E; Severinov K
    Nucleic Acids Res; 2017 Feb; 45(4):1946-1957. PubMed ID: 28130424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of T7 phage and T7 phage containing apurinic sites in an exonuclease III, endonuclease IV double mutant of Escherichia coli.
    Sanchez G; Mamet-Bratley MD
    Biochem Cell Biol; 1992 Jul; 70(7):605-8. PubMed ID: 1280443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the unassembled capsid protein during infection of Shigella sonnei by bacteriophage T7 results in DNA damage that is repairable by bacteriophage T3, but not T7, DNA ligase.
    Beck PJ; Condreay JP; Molineux IJ
    J Bacteriol; 1986 Jul; 167(1):251-6. PubMed ID: 3522545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed bacteriophage infection of Escherichia coli: exclusion of superinfecting T4 by T7.
    Loewen RR; Miller RC; Warren RA
    Can J Microbiol; 1979 Aug; 25(8):867-73. PubMed ID: 393371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological properties of a T7-T3 recombinant bacteriophage that productively infects strains of Escherichia coli that harbor the F plasmid.
    Spence JL; Mooney PQ; Molineux IJ
    J Virol; 1983 Jun; 46(3):895-900. PubMed ID: 6343628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.